Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?
Titel:
Perspective: Clinical relevance of the dichotomous classification of Alzheimer's disease biomarkers: Should there be a “gray zone”?
Auteur:
McRae-McKee, Kevin Udeh-Momoh, Chinedu T. Price, Geraint Bajaj, Sumali de Jager, Celeste A. Scott, David Hadjichrysanthou, Christoforos McNaughton, Emily Bracoud, Luc Ahmadi-Abhari, Sara de Wolf, Frank Anderson, Roy M. Middleton, Lefkos T.